These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 37026262)
41. A protocol for a single center, randomized, controlled trial comparing the clinical efficacy of 3% diquafosol and 0.1% hyaluronic acid in diabetic patients with dry eye disease. Chen J; Chen Y; Qin G; Li L; Li M; Cheng Y; Zhuang S; Li Z; Zhang Q; Wu Y; Yang L; Moutari S; Moore JE; Xu L; He W; Yu S; Pazo EE; He X Trials; 2023 Dec; 24(1):803. PubMed ID: 38087329 [TBL] [Abstract][Full Text] [Related]
42. A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients. Takamura E; Tsubota K; Watanabe H; Ohashi Y; Br J Ophthalmol; 2012 Oct; 96(10):1310-5. PubMed ID: 22914501 [TBL] [Abstract][Full Text] [Related]
43. An Updated Systematic Review With Meta-Analysis Of Randomized Trials On Topical Cyclosporin A For Dry-Eye Disease. Tuan HI; Chi SC; Kang YN Drug Des Devel Ther; 2020; 14():265-274. PubMed ID: 32021110 [TBL] [Abstract][Full Text] [Related]
44. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time. Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481 [TBL] [Abstract][Full Text] [Related]
45. Autologous serum eye drops for dry eye. Pan Q; Angelina A; Zambrano A; Marrone M; Stark WJ; Heflin T; Tang L; Akpek EK Cochrane Database Syst Rev; 2013 Aug; 8(8):CD009327. PubMed ID: 23982997 [TBL] [Abstract][Full Text] [Related]
46. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery. Mencucci R; Boccalini C; Caputo R; Favuzza E J Cataract Refract Surg; 2015 Aug; 41(8):1699-704. PubMed ID: 26432128 [TBL] [Abstract][Full Text] [Related]
47. A randomized controlled trial involving college student: Comparing 0.15% hyaluronic acid with 0.05% cyclosporine A and 3% diquafosol sodium in the Treatment of Dry Eye. Xu W; Zhao X; Jin H; Jin H; Jia F; Jiang L; Li Z Medicine (Baltimore); 2023 Sep; 102(36):e34923. PubMed ID: 37682142 [TBL] [Abstract][Full Text] [Related]
48. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease. Mun Y; Kwon JW; Oh JY BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156 [TBL] [Abstract][Full Text] [Related]
49. A Clinic-based Survey of Clinical Characteristics and Practice Pattern of Dry Eye in Japan. Kawashima M; Yamada M; Suwaki K; Shigeyasu C; Uchino M; Hiratsuka Y; Yokoi N; Tsubota K; Adv Ther; 2017 Mar; 34(3):732-743. PubMed ID: 28181147 [TBL] [Abstract][Full Text] [Related]
50. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease. Lee HS; Ji YS; Yoon KC Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018 [TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K; Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038 [TBL] [Abstract][Full Text] [Related]
52. Comparing two mucin secretagogues for the treatment of dry eye disease: a prospective randomized crossover trial. Jin Y; Seo KY; Kim SW Sci Rep; 2024 Jun; 14(1):13306. PubMed ID: 38858411 [TBL] [Abstract][Full Text] [Related]
53. A comparison between hyaluronic acid and other single ingredient eye drops for dry eye, a review. Hynnekleiv L; Magno M; Moschowits E; Tønseth KA; Vehof J; Utheim TP Acta Ophthalmol; 2024 Feb; 102(1):25-37. PubMed ID: 37042308 [TBL] [Abstract][Full Text] [Related]
54. Efficacy and Safety of the Long-Acting Diquafosol Ophthalmic Solution DE-089C in Patients with Dry Eye: A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study. Hori Y; Oka K; Inai M Adv Ther; 2022 Aug; 39(8):3654-3667. PubMed ID: 35716319 [TBL] [Abstract][Full Text] [Related]
55. Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study. Ohashi Y; Munesue M; Shimazaki J; Takamura E; Yokoi N; Watanabe H; Nomura A; Shimada F Adv Ther; 2020 Feb; 37(2):707-717. PubMed ID: 31834617 [TBL] [Abstract][Full Text] [Related]
56. Diquafosol sodium reduces neuronal activity in trigeminal subnucleus caudalis in a rat model of chronic dry eye disease. Katagiri A; Tsubota K; Mikuzuki L; Nakamura S; Toyofuku A; Kato T; Bereiter DA; Iwata K Neurosci Lett; 2023 Jan; 792():136939. PubMed ID: 36341926 [TBL] [Abstract][Full Text] [Related]
58. Effectiveness of rb-bFGF Eye Drops for Post-Cataract Surgery Dry Eye and Observation of Changes in Tear Secretion and Corneal Damage in Patients. Zhao X; Jia Q; Fu J Altern Ther Health Med; 2023 Nov; 29(8):489-495. PubMed ID: 37652420 [TBL] [Abstract][Full Text] [Related]
59. Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study. Fukuoka S; Arita R Sci Rep; 2019 Jun; 9(1):9091. PubMed ID: 31235821 [TBL] [Abstract][Full Text] [Related]